Do melatonin supplements work for sleep? OTC options explained

Do melatonin supplements work for sleep?

The answer depends on the sleep problem and the product. Evidence for a licensed melatonin medicine in a defined patient group does not prove that every supplement treats insomnia.

Melatonin is a hormone involved in the sleep-wake cycle. A product's strength, release pattern and timing can affect its use. More milligrams are not a reliable shortcut to better sleep, and this guide does not give a self-selected supplement dose.

Prescription evidence is indication-specific

The EMA authorises Circadin, a prolonged-release melatonin medicine, for short-term treatment of primary insomnia characterised by poor sleep quality in people aged 55 or older. That indication should not be generalised to younger adults, every cause of insomnia or all immediate-release supplements.

UK NHS guidance also describes prescribed melatonin for certain sleep problems and jet lag. Jet lag and persistent insomnia are different questions; a product suited to one is not automatically suitable for the other.

Ask which diagnosis and formulation the recommendation concerns, what benefit is realistic, and how response will be reviewed. A natural hormone can still have side effects and interactions.

Two sourced country examples

The French advice is a dated safety reference, not a claim that its historical dose threshold proves current legality. Classification, product authorisation and cross-border sale should be checked locally with a pharmacist.

Safety questions before use

ANSES advises avoiding melatonin supplements in pregnancy, breastfeeding, children and adolescents, and people with inflammatory or autoimmune disease. It recommends medical advice for people with epilepsy, asthma, mood or behavioural disorders, or those taking medicines.

Drowsiness can be a safety problem when alertness is needed. Do not drive or operate machinery if affected. Tell a professional about other sleep medicines, supplements and alcohol use before combining products.

A supplement label saying “natural” does not establish that the product is safe for you or equivalent to a medicine.

When to seek help for sleep

If poor sleep persists, affects daily functioning or accompanies snoring and interrupted breathing, arrange assessment. Keep a record of sleep timing, caffeine, alcohol, medicines and daytime symptoms to support the discussion.

Regular sleep habits and, where appropriate, cognitive behavioural therapy are part of insomnia care. Repeatedly increasing a supplement dose can postpone finding the cause.

Information and clinical decisions

This guide provides general information, not a diagnosis or personal treatment plan. Any clinical assessment and prescribing decision rests with an independent clinician. Prescrivia is a technology intermediary, not a medical provider or pharmacy; it does not prescribe, sell or dispense medicines. Assessment does not guarantee a prescription, medicine availability or a health outcome.

Further reading: treatment information.

Read about online consultations and their limits. Service information must not delay urgent local care.

Sources

1. EMA: Circadin — Prolonged-release medicine authorised for short-term primary insomnia in people aged 55 or older; product-specific evidence.
2. NHS: melatonin — UK prescription-only status and indication-specific use, including jet lag.
3. ANSES: melatonin supplement safety advice, April 2018 — French supplement context, at-risk groups and medical-advice recommendations; historical rather than current legal clearance.
4. NHS: insomnia care — Assessment of ongoing sleep difficulty and non-medicine approaches.

See the current clinical, legal and language review statuses for this edition. Source checks are editorial work, not approval.